Wells Fargo & Company Nektar Therapeutics Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Nektar Therapeutics stock. As of the latest transaction made, Wells Fargo & Company holds 82,480 shares of NKTR stock, worth $96,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,480

Previous 5,134 1506.54%

Holding current value

$96,501

Previous $4,000 2450.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.9 - $1.83 $69,611 - $141,543	77,346 Added 1506.54%	82,480 $102,000
Q1 2024 May 10, 2024	BUY	$0.49 - $0.96 $12 - $24	26 Added 0.51%	5,134 $4,000
Q4 2023 Feb 09, 2024	SELL	$0.42 - $0.57 $28 - $39	-69 Reduced 1.33%	5,108 $2,000
Q3 2023 Nov 13, 2023	SELL	$0.51 - $1.05 $1,786 - $3,678	-3,503 Reduced 40.36%	5,177 $3,000
Q2 2023 Aug 15, 2023	SELL	$0.53 - $1.03 $31,617 - $61,445	-59,656 Reduced 87.3%	8,680 $5,000
Q1 2023 May 12, 2023	BUY	$0.64 - $3.15 $34,997 - $172,254	54,684 Added 400.56%	68,336 $47,000
Q4 2022 Feb 13, 2023	SELL	$2.03 - $4.28 $16,782 - $35,382	-8,267 Reduced 37.72%	13,652 $30,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $726 - $1,228	-239 Reduced 1.08%	21,919 $70,000
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $276,439 - $538,054	-87,205 Reduced 79.74%	22,158 $84,000
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $23,075 - $76,104	-5,547 Reduced 4.83%	109,363 $590,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $517,533 - $879,758	-47,787 Reduced 29.37%	114,910 $1.55 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $275,959 - $397,787	-21,114 Reduced 11.49%	162,697 $2.92 Million
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $127,815 - $157,834	-7,737 Reduced 4.04%	183,811 $3.16 Million
Q1 2021 May 13, 2021	SELL	$16.56 - $25.46 $1.03 Million - $1.58 Million	-61,967 Reduced 24.44%	191,548 $3.83 Million
Q4 2020 Feb 09, 2021	BUY	$15.77 - $19.03 $1.28 Million - $1.54 Million	81,011 Added 46.96%	253,515 $4.31 Million
Q3 2020 Nov 05, 2020	SELL	$16.59 - $24.79 $1.49 Million - $2.23 Million	-89,888 Reduced 34.26%	172,504 $2.86 Million
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $88,194 - $122,614	-5,231 Reduced 1.95%	262,392 $6.08 Million
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $3.87 Million - $7.48 Million	267,623 New	267,623 $4.78 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Nektar Therapeutics Transaction History